Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Redfield

Showing results (1021-1030 of 1,078) with videos related to

Pageof 108
Sort By:
JAMA Cardiology|July 13, 2017
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical TrialJaved Butler, Kevin J Anstrom, G Michael Felker, et al.
JACC. Heart Failure|April 28, 2022
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialMaja Cikes, Ivo Planinc, Brian Claggett, et al.
JAMA Cardiology|November 3, 2021
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialDouglas L Mann, Michael M Givertz, Justin M Vader, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2025
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damageBrian C Netzel, M Cristine Charlesworth, Kenneth L Johnson, et al.
Circulation|March 24, 2020
Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group SummarySanjiv J Shah, Barry A Borlaug, Dalane W Kitzman, et al.
JAMA|May 17, 2017
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical TrialGregory D Lewis, Rajeev Malhotra, Adrian F Hernandez, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Mayo Clinic Proceedings|November 13, 2001
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodelingA Cataliotti, L S Malatino, M Jougasaki, et al.
The American Journal of Hospice & Palliative Care|August 28, 2020
Early Use of the Palliative Approach to Improve Patient Outcomes in HIV Disease: Insights and Findings From the Care and Support Access (CASA) Study 2013-2019Carla S Alexander, Victoria H Raveis, Daniel Karus, et al.
European Journal of Heart Failure|December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HFXiaowen Wang, Orly Vardeny, Brian Claggett, et al.
Pageof 108

Showing results (1021-1030 of 1,078) with videos related to

Sort By:
Pageof 108
JAMA Cardiology|July 13, 2017
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical TrialJaved Butler, Kevin J Anstrom, G Michael Felker, et al.
JACC. Heart Failure|April 28, 2022
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialMaja Cikes, Ivo Planinc, Brian Claggett, et al.
JAMA Cardiology|November 3, 2021
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialDouglas L Mann, Michael M Givertz, Justin M Vader, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2025
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damageBrian C Netzel, M Cristine Charlesworth, Kenneth L Johnson, et al.
Circulation|March 24, 2020
Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group SummarySanjiv J Shah, Barry A Borlaug, Dalane W Kitzman, et al.
JAMA|May 17, 2017
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical TrialGregory D Lewis, Rajeev Malhotra, Adrian F Hernandez, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Mayo Clinic Proceedings|November 13, 2001
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodelingA Cataliotti, L S Malatino, M Jougasaki, et al.
The American Journal of Hospice & Palliative Care|August 28, 2020
Early Use of the Palliative Approach to Improve Patient Outcomes in HIV Disease: Insights and Findings From the Care and Support Access (CASA) Study 2013-2019Carla S Alexander, Victoria H Raveis, Daniel Karus, et al.
European Journal of Heart Failure|December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HFXiaowen Wang, Orly Vardeny, Brian Claggett, et al.
Pageof 108